A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients

Clinical trial NCT04811196 · COMPLETED

Trial details

NCT number: NCT04811196
Sponsor: University Health Network, Toronto
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Soft Tissue Sarcoma Malignant Peripheral Nerve Sheath Tumor (MPNST)Leiomyosarcoma Endometrial Stromal Sarcoma

Start date: 2021-03-29
Primary completion: 2025-05-15
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.